Integer Holdings Corporation Reports Second Quarter 2026 Results

Integer reported Q2 sales of $464 million, down 2.6% year-over-year, with adjusted EPS of $1.60 and adjusted EBITDA of $95 million. Sales declines were driven by the Cardio & Vascular and Other Markets segments, partially offset by growth in Cardiac Rhythm Management & Neuromodulation. The company announced it has entered into a definitive agreement to be acquired by an affiliate of KKR in an all-cash transaction valued at $5.7 billion, or $127 per share.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.